Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Fish and Richardson
QuintilesIMS
Covington
Chinese Patent Office
Federal Trade Commission
AstraZeneca
Accenture

Generated: February 18, 2019

DrugPatentWatch Database Preview

Pliva Company Profile

« Back to Dashboard

What is the competitive landscape for PLIVA, and what generic and branded alternatives to PLIVA drugs are available?

PLIVA has eighty-nine approved drugs.

There are six tentative approvals on PLIVA drugs.

Summary for Pliva
US Patents:0
Tradenames:55
Ingredients:53
NDAs:89
Drug Master File Entries: 1
Patent Litigation for Pliva: See patent lawsuits for Pliva

Drugs and US Patents for Pliva

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva Lachema CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 078631-001 Dec 2, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Pliva IBUPROFEN ibuprofen TABLET;ORAL 071668-001 Jun 18, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pliva Pharm Ind TORSEMIDE torsemide TABLET;ORAL 076346-003 May 30, 2003 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Pliva ULTRAGRIS-330 griseofulvin, ultramicrocrystalline TABLET;ORAL 062646-001 Jun 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Pliva Pharm Ind TORSEMIDE torsemide TABLET;ORAL 076346-002 May 30, 2003 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Fish and Richardson
Cantor Fitzgerald
Deloitte
Accenture
Argus Health
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.